Metraipolis › archive › dc_fc9c8bfa58bf

Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study — Europe PMC PMID:41004466

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41004466
DOI: 10.1371/journal.pone.0328929
License (as archived): solo-consultazione
Archived: 2026-11-09T18:13:22.372Z
SHA-256 of the archived text: fc8fef4a5d53c3868017826bf0214c9d3c0a579524f6eab84b14d8eecdb012d2
Stable URL of this page: https://metraipolis.com/documento/dc_fc9c8bfa58bf

How to cite

Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study — Europe PMC PMID:41004466 — Europe PMC (en), https://europepmc.org/article/MED/41004466 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc9c8bfa58bf (Metraipolis archive dc_fc9c8bfa58bf, sha256 fc8fef4a5d53c3868017826bf0214c9d3c0a579524f6eab84b14d8eecdb012d2)

BibTeX

@misc{dcfc9c8bfa58bf,
  title = {Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study — Europe PMC PMID:41004466},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41004466},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc9c8bfa58bf; sha256 fc8fef4a5d53c3868017826bf0214c9d3c0a579524f6eab84b14d8eecdb012d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41004466. Agents can read the archived copy with the MCP tool read_document.